Can atropine eye drops be used for glaucoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atropine Eye Drops Are Not Recommended for Glaucoma Treatment

Atropine eye drops should not be used for glaucoma treatment as they can increase intraocular pressure (IOP) and potentially worsen glaucomatous damage. 1

Mechanism of Action and Contraindication

  • Atropine is an anticholinergic agent that causes pupillary dilation (mydriasis) and cycloplegia, which can lead to angle closure and increased IOP in susceptible individuals 1
  • Research in animals has demonstrated that topical atropine application can significantly increase IOP, making it unsuitable for glaucoma management 1
  • Atropine's mechanism directly opposes the goals of glaucoma therapy, which aims to reduce IOP to prevent further optic nerve damage 2

Recommended First-Line Treatments for Glaucoma

  • Prostaglandin analogs are the recommended first-line medical therapy for primary open-angle glaucoma due to their superior efficacy (20-35% IOP reduction), once-daily dosing, and favorable side effect profile 3
  • When selecting glaucoma medication, the goal is to maintain IOP in a range where visual field loss is unlikely to significantly affect quality of life 2
  • A reasonable target IOP is typically 20% lower than baseline measurements, based on the Ocular Hypertension Treatment Study (OHTS) 2

Alternative Medication Classes for Glaucoma

  • Beta-adrenergic antagonists (e.g., timolol) can reduce IOP by 15-25% but may cause systemic side effects like bradycardia and bronchospasm 3, 4
  • Alpha-2 adrenergic agonists (e.g., brimonidine) can reduce IOP by 15-25% but may cause ocular allergic reactions 3
  • Topical and oral carbonic anhydrase inhibitors decrease aqueous production and can reduce IOP by 15-30% 2
  • Rho kinase inhibitors (e.g., netarsudil) increase trabecular outflow and can reduce IOP by 10-20% 2, 5

Treatment Algorithm for Glaucoma

  1. Start with a prostaglandin analog as first-line therapy unless contraindicated 3
  2. If target IOP is not achieved with a single medication, consider:
    • Adding a second medication from a different class 3
    • Using fixed-combination therapy to improve adherence 2
    • Evaluating for laser trabeculoplasty as an alternative or adjunctive therapy 3, 5
  3. Monitor IOP, optic nerve structure, and visual fields regularly to assess treatment efficacy 3

Potential Pitfalls in Glaucoma Management

  • Poor medication adherence is common and can be improved with once-daily dosing regimens 2, 6
  • Ignoring systemic comorbidities when selecting medications can lead to adverse effects 3, 4
  • Inadequate follow-up can result in disease progression despite treatment 3
  • Using medications that can increase IOP (like atropine) can worsen glaucomatous damage 1

Appropriate Uses for Atropine Eye Drops

  • Atropine is indicated for myopia control in children, not for glaucoma treatment 2
  • Low-dose atropine (0.01%-0.05%) has been shown to slow myopia progression with minimal side effects 2
  • Atropine may be used for other ophthalmic conditions like uveitis or prior to certain eye examinations, but is contraindicated in glaucoma 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Best Medication for Lowering Intraocular Pressure in Primary Open-Angle Glaucoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current management of glaucoma.

The Medical journal of Australia, 2019

Research

[Possibilities and limitations of eye drops for glaucoma therapy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.